TUMOR VOLUME AS PROGNOSTIC FACTOR IN CHEMORADIATION FOR ADVANCED HEAD AND NECK CANCER

被引:76
作者
Knegjens, Joost L. [1 ]
Hauptmann, Michael [2 ]
Pameijer, Frank A. [3 ]
Balm, Alfons J. [4 ,5 ]
Hoebers, Frank J. [1 ]
de Bois, Josien A. [1 ]
Kaanders, Johannes H. [6 ]
van Herpen, Carla M. [7 ]
Verhoef, Cornelia G. [8 ]
Wijers, Oda B. [9 ]
Wiggenraad, Ruud G. [10 ]
Buter, Jan [11 ]
Rasch, Coen R. [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Bioinformat & Stat, Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands
[7] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[8] Arnhem Radiotherapy Inst, Arnhem, Netherlands
[9] Radiotherapy Inst Friesland, Leeuwarden, Netherlands
[10] Haaglanden Med Ctr, Dept Radiat Oncol, The Hague, Netherlands
[11] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2011年 / 33卷 / 03期
关键词
head and neck cancer; radiotherapy; chemoradiation; tumor volume; prognostic factor; SQUAMOUS-CELL CARCINOMA; LOCAL-CONTROL; CONCURRENT CHEMORADIOTHERAPY; HYPOPHARYNGEAL CANCER; RADIATION-THERAPY; RANDOMIZED-TRIAL; DOSE CISPLATIN; PHASE-III; RADIOTHERAPY; CT;
D O I
10.1002/hed.21459
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Tumor volume is an important predictor of outcome in radiotherapy alone. Its significance in concomitant chemoradiation (CCRT) is much less clear. We analyzed the prognostic value of primary tumor volume for advanced head and neck squamous cell carcinoma (HNSCC) treated with CCRT. Methods. Three hundred sixty patients treated with definitive CCRT for advanced HNSCC were selected. The pretreatment MRI or CT scan was used to calculate the primary tumor volume. Median follow-up was 19.8 months. Results. The average primary tumor volume was 37.0 cm(3) (range, 2.1-182.7 cm(3); median, 28.7 cm(3)). Multivariate analysis showed a significant effect of tumor volume on local control. The hazard ratio for a local recurrence increased by 14% per 10 cm(3) volume increase (95% CI, 8% to 21%). There was no significant independent effect of T and N status on local control. Conclusion. For advanced HNSCC, tumor volume is more powerful for predicting outcome after CCRT than TNM status. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 375-382, 2011
引用
收藏
页码:375 / 382
页数:8
相关论文
共 45 条
[31]   Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer [J].
Posner, Marshall R. ;
Hershock, Diane M. ;
Blajman, Cesar R. ;
Mickiewicz, Elizabeth ;
Winquist, Eric ;
Gorbounova, Vera ;
Tjulandin, Sergei ;
Shin, Dong M. ;
Cullen, Kevin ;
Ervin, Thomas J. ;
Murphy, Barbara A. ;
Raez, Luis E. ;
Cohen, Roger B. ;
Spaulding, Monica ;
Tishler, Roy B. ;
Roth, Berta ;
del Carmen Viroglio, Rosana ;
Venkatesan, Varagur ;
Romanov, Ilya ;
Agarwala, Sanjiv ;
Harter, K. William ;
Dugan, Matthew ;
Cmelak, Anthony ;
Markoe, Arnold M. ;
Read, Paul W. ;
Steinbrenner, Lynn ;
Colevas, A. Dimitrios ;
Norris, Charles M., Jr. ;
Haddad, Robert I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (17) :1705-1715
[32]   Measurement by multidetector CT scan of the volume of hypopharyngeal and laryngeal tumours: accuracy and reproducibility [J].
Preda, Lorenzo ;
Lovati, Elena ;
Chiesa, Fausto ;
Ansarin, Mohssen ;
Cattaneo, Laura ;
Fasani, Roberta ;
Gandini, Sara ;
Flor, Nicola ;
Cornalba, Gianpaolo ;
Bellomi, Massimo .
EUROPEAN RADIOLOGY, 2007, 17 (08) :2096-2102
[33]   The potential impact of CT-MRI matching on tumor volume delineation in advanced head and neck cancer [J].
Rasch, C ;
Keus, R ;
Pameijer, FA ;
Koops, W ;
deRu, V ;
Muller, S ;
Touw, A ;
Bartelink, H ;
vanHerk, M ;
Lebesque, JV .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (04) :841-848
[34]   Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer, early results of a multi-institutional trial [J].
Rasch, C. R. N. ;
Salverda, G. J. ;
Schornagel, J. H. ;
Kroger, R. ;
Wiggenraad, R. ;
Buter, J. ;
Rietveld, D. ;
Ackerstaf, A. ;
Oughlane-Heemsbergen, W. D. ;
Balm, F. J. M. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03) :S1-S2
[35]   RAPID SUPERSELECTIVE HIGH-DOSE CISPLATIN INFUSION FOR ADVANCED HEAD AND NECK MALIGNANCIES [J].
ROBBINS, KT ;
STORNIOLO, AM ;
KERBER, C ;
SEAGREN, S ;
BERSON, A ;
HOWELL, SB .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1992, 14 (05) :364-371
[36]   Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy [J].
Rudat, V ;
Dietz, A ;
Schramm, O ;
Conradt, C ;
Maier, H ;
Flentje, M ;
Wannenmacher, M .
RADIOTHERAPY AND ONCOLOGY, 1999, 53 (02) :119-125
[37]   Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: evolution of a model beyond TNM staging [J].
Salesiotis, AN ;
Cullen, KJ .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (03) :229-239
[38]  
Sobin L., 2002, UICC: TNM Classification of malignant tumors, V6th
[39]   Volumetric staging (VS) is superior to TNM and AJCC staging in predicting outcome of head and neck cancer treated with IMRT [J].
Studer, G. ;
Luetolf, U. M. ;
El-Bassiouni, M. ;
Rousson, V. ;
Glanzmann, C. .
ACTA ONCOLOGICA, 2007, 46 (03) :386-394
[40]   Analysis of prognostic factors of chemoradiation therapy for advanced hypopharyngeal cancer - Does tumor volume correlate with central necrosis and tumor pathology? [J].
Tsou, Yung An ;
Hua, Jun Hong ;
Lin, Meng Hung ;
Tsai, Ming Hsui .
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 2006, 68 (04) :206-212